柴胡注射液结合TACE技术治疗肝癌效果观察

Effective observation on treating liver cancer with the Chaihu injection plus TACE technology

目的:观察柴胡注射液结合肝动脉化疗栓塞术(TACE)对肝癌患者血清中AFP、nm23、CD44、Bcl-2含量水平的影响,结合生存率评估其治疗效果。方法:收集整理我院肝癌患者60例,随机分为两组,对照组30例进行肝动脉化疗栓塞术(TACE),实验组30例采用TACE联合静点滴入柴胡注射液治疗。结果:治疗后实验组患者血清AFP、CD44含量水平低于对照组(P<0.01);治疗后实验组患者血清nm23、Bcl-2含量水平高于对照组(P<0.01);与对照组比较,实验组生存率较高,不良反应发生率较低(P<0.05)。结论:柴胡注射液结合TACE技术有较好的治疗效果,希望在肝癌治疗方面得到推广。

Objective:To observe the effect of the Chaihu injection plus transcatheter arterial chemoembolization on serum AFP,nm23,CD44and Bcl-2levels in patients with hepatocellular carcinoma,and to evaluate the therapeutic effect of BACE based on survival.Methods:60cases were randomly divided into two groups.The control group of30cases underwent TACE.30patients in the experimental group were treated by TACE plus intravenous injection of the Chaihu injection.Results:The levels of serum AFP and CD44in the experimental group were lower than those in the control group(P<0.01).The levels of serum nm23and Bcl-2in the experimental group were higher than those in the control group(P<0.01).Compared with the control group,the survival in the experimental group was higher and adverse reactions were lower(P<0.05).Conclusion:The Chaihu injection plus TACE has a good therapeutic effect,is worthy of promotion in clinical practice.